approval
saveTRIUMEQ PD (ABACAVIR SULFATE) — FDA approval
March 30, 2022updated 5mo ago
community read0 votes
Sponsor: VIIV HLTHCARE. Form: TABLET, FOR SUSPENSION. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
same company · ±60 days · 6
- approvalTRIUMEQ (ABACAVIR SULFATE) — FDA approvalMar 30, 2022
- approvalCABENUVA KIT (CABOTEGRAVIR) — FDA approvalMar 29, 2022
- approvalCABENUVA KIT (CABOTEGRAVIR) — FDA approvalMar 29, 2022
- approvalCABENUVA KIT (CABOTEGRAVIR) — FDA approvalMar 23, 2022
- approvalCABENUVA KIT (CABOTEGRAVIR) — FDA approvalFeb 7, 2022
- approvalCABENUVA KIT (CABOTEGRAVIR) — FDA approvalJan 31, 2022
comments(0)
5-min edit window · permanent after that